英文摘要 |
Purposes: Smoking could worsen chronic kidney disease (CKD) and is also a risk factor for many diseases, such as cardiovascular disease and cancer. In comparison, smoking cessation delays the deterioration of renal function and is widely used in disease prevention. This study aimed to explore the effects of smoking cessation in CKD patients in terms of use of renal replacement therapy (RRT), cancer diagnosis, and survival during follow-up. Methods This study employed a longitudinal comparative panel design. Purposive sampling was used on subjects who received smoking cessation program at a medical center in central Taiwan. There were 33 enrolled participants, of which 11 were ex-smokers and 20 failed to quit smoking (smoking group). The study was conducted from December 2008 to December 2015, with a total follow-up period of 7 years. Data was collected and compared across both groups. Results There were no significant difference in RRT usage (n=8, 61.5% versus n=9, 45.0%, p>0.05) and proportion of subjects who developed cancer (n=3, 23.1% versus n=10, 50.0%, p>0.05) between the two groups. The proportion of cancer mortality was significantly lower in the ex-smoker group than the smoking group (n=1, 33.3% versus n=10, 100%, p0.05). Conclusions This study showed that smoking cessation could help delay cancer mortality in CKD patients as subjects in the smoking group had a higher mortality. These findings may provide a reference to medical staff in executing smoking cessation programs to improve the quality of care for CKD patients. |